Movement Disorders

A recent webinar summarized on-going efforts to halt Parkinson disease, including several phase III trials.

Dysregulated dopamine may not be the sole cause of impulse control problems in patients with Parkinson disease.

Dopamine may not be the only neurotransmitter affected in Parkinson disease.

A Johns Hopkins team is designing the STIMband, a non-invasive brain-stimulating device that may provide at-home Parkinson treatment.

Researchers test a compound that shows promise as a Parkinson treatment.

Studies of a kuru epidemic in a formerly cannibalistic tribe could lead to further understanding of other neurodegenerative diseases, such as Alzheimer and Parkinson.

Our blogger discusses a recent study investigating the likelihood of head trauma in older patients leading to the onset of Parkinson disease and the implications of the findings.

Patients with PD commonly suffer from depression. A recent cohort study investigated the association between depression and subsequent PD diagnosis.

New PD medications and treatments are being developed and novel uses for existing drugs are being discovered.

Deep brain stimulation, stem cell treatment, studying mitochondria-to mark Parkinson’s Awareness Month, we review some noteworthy new concepts.

Advances in neurology science and patient care continue to make news even before the doors to the AAN 2015 Annual Meeting officially open on Saturday. These are the top stories.

There’s a new app for tracking symptoms of Parkinson disease, Alzheimer and Parkinson diseases may share characteristics with mad cow disease, and a skin test may one day be used to detect both AD and PD.

These agents lower cholesterol and prevent cardiovascular disease, but they may actually increase the risk of Parkinson disease. Caution advised.

Drugs often involve multiple daily doses with complex dosing regimens, but interventions that have been applied generically to patients with chronic diseases can be applied to these cases as well.

Scientists are testing alternative therapeutic approaches that may delay disease progression and even protect and regenerate neurons.

Orexin B protects vulnerable midbrain neurons from degeneration and preserves their function. This sleep-promoting protein could provide a new target for potential treatments.

Men and women smoke for different reasons and activate different parts of the brain while smoking. These findings from “dopamine movies” could have implications for Parkinson disease.

What happens before the demyelinating lesions of MS appear? Does smoking confer protection against Parkinson disease? How is NMDA receptor-associated disease reversed? Here are 4 fine papers from 2014 that set out to answer these questions.

Parkinson and other neurodegenerative diseases are hard to distinguish. Surface-based MRI shows promise as a diagnostic tool.

Get to the root of the latest research findings on nervous system disorders and test your brainpower with this quick 5-question quiz.

The latest scientific developments about the brain and how it works were presented this week at the annual meeting of the Society for Neuroscience. Potential new treatments were identified.

These findings advance knowledge about the link between brain inflammation and the progression of brain disorders and suggest possible targets for future treatments.